Metraipolis › archive › dc_e3560fd92fb0

Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma — Europe PMC PMID:41602546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41602546
DOI
10.3389/fmolb.2025.1681888
License (as archived)
solo-consultazione
Archived
2026-11-06T21:05:21.693Z
SHA-256 of the archived text
511d209430745d181beb538f5054592fc6f0bd996ab75b9deb9780c009574fd7
Stable URL of this page
https://metraipolis.com/documento/dc_e3560fd92fb0

How to cite

Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma — Europe PMC PMID:41602546 — Europe PMC (en), https://europepmc.org/article/MED/41602546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e3560fd92fb0 (Metraipolis archive dc_e3560fd92fb0, sha256 511d209430745d181beb538f5054592fc6f0bd996ab75b9deb9780c009574fd7)
BibTeX
@misc{dce3560fd92fb0,
  title = {Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma — Europe PMC PMID:41602546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41602546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e3560fd92fb0; sha256 511d209430745d181beb538f5054592fc6f0bd996ab75b9deb9780c009574fd7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41602546. Agents can read the archived copy with the MCP tool read_document.